Domino liver transplantation: How far can we push the paradigm?

Liver Transplantation

Volumn 18, Issue 1, 2012, Pages 22-28

  Popescu, Irinel ^a,b   Dima, Simona O ^a  

^a FUNDENI CLINICAL INSTITUTE   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE INTERMITTENT PORPHYRIA; DOMINO LIVER TRANSPLANTATION; EXPLANT; FAMILIAL AMYLOID POLYNEUROPATHY; FAMILIAL HYPERCHOLESTEROLEMIA; GRAFT RECIPIENT; HUMAN; HYPEROXALURIA; LIVER CELL CARCINOMA; LIVER GRAFT; LIVER TRANSPLANTATION; MAPLE SYRUP URINE DISEASE; NEUROTOXICITY; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

HEPATECTOMY; HUMANS; LIVER; LIVER TRANSPLANTATION; METABOLIC DISEASES; RARE DISEASES; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 84255187722     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22443     Document Type: Review

References (50)

1. Tincani G, Hoti E, Andreani P, Ricca L, Pittau G, Vitale V, et al. Operative risks of domino liver transplantation for the familial amyloid polyneuropathy liver donor and recipient: a double analysis. Am J Transplant 2011; 11: 759-766.
2. Familial Amyloidotic Polyneuropathy World Transplant Registry and Domino Liver Transplant Registry. Accessed September 2011.
3. Roels L, Rahmel A,. The European experience. Transpl Int 2011; 24: 350-367.
4. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699. (Pubitemid 26079803)
5. Casas-Melley AT, Thomas PG, Krueger LJ, Falkenstein KP, Flynn LM, Conley SB, Dunn SP,. Domino as a bridge to definitive liver transplantation in a neonate. Pediatr Transplant 2002; 6: 249-254. (Pubitemid 34836284)
6. Furtado A, Tomé L, Oliveira FJ, Furtado E, Viana J, Perdigoto R,. Sequential liver transplantation. Transplant Proc 1997; 29: 467-468. (Pubitemid 27123489)
7. Furtado L, Oliveira F, Furtado E, Geraldes B, Reis A, Viana J, et al. Maximum sharing of cadaver liver grafts composite split and domino liver transplants. Liver Transpl Surg 1999; 5: 157-158. (Pubitemid 29118221)
8. Marín-Gõmez LM, Gõmez-Bravo MA, Barrera-Pulido L, Bernal-Bellido C, Alamo-Martínez JM, Suárez-Artacho G, et al. Outcomes of domino liver transplantation: a single institution's experience. Transplant Proc 2010; 42: 644-646.
9. Bispo M, Marcelino P, Marques HP, Martins A, Perdigoto R, Aguiar MJ, et al. Domino versus deceased donor liver transplantation: association with early graft function and perioperative bleeding. Liver Transpl 2011; 17: 270-278.
10. Stangou AJ, Heaton ND, Hawkins PN,. Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation. N Engl J Med 2005; 352: 2356. (Pubitemid 40740565)
11. Lladõ L, Baliellas C, Casasnovas C, Ferrer I, Fabregat J, Ramos E, et al. Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation. Liver Transpl 2010; 16: 1386-1392.
12. Stangou AJ, Banner NR, Hendry BM, Rela M, Portmann B, Wendon J, et al. Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood 2010; 115: 2998-3007.
13. Donckier V, El Nakadi I, Closset J, Ickx B, Louis H, Le Moine O, et al. Domino hepatic transplantation using the liver from a patient with primary hyperoxaluria. Transplantation 2001; 71: 1346-1348. (Pubitemid 32507161)
14. Franchello A, Paraluppi G, Romagnoli R, Petrarulo M, Vitale C, Pacitti A, et al. Severe course of primary hyperoxaluria and renal failure after domino hepatic transplantation. Am J Transplant 2005; 5: 2324-2327. (Pubitemid 41648485)
15. Farese S, Trost N, Candinas D, Huynh-Do U,. Early renal failure after domino hepatic transplantation using the liver from a compound heterozygous patient with primary hyperoxaluria. Nephrol Dial Transplant 2005; 20: 2557-2560. (Pubitemid 41548890)
16. Saner FH, Treckmann J, Pratschke J, Arbogast H, Rahmel A, Vester U, Paul A,. Early renal failure after domino liver transplantation using organs from donors with primary hyperoxaluria type 1. Transplantation 2010; 90: 782-785.
17. Dowman JK, Gunson BK, Bramhall S, Badminton MN, Newsome PN,. Liver transplantation from donors with acute intermittent porphyria. Ann Intern Med 2011; 154: 571-572.
18. Khanna A, Hart M, Nyhan WL, Hassanein T, Panyard-Davis J, Barshop BA,. Domino liver transplantation in maple syrup urine disease. Liver Transpl 2006; 12: 876-882.
19. Mazariegos G, Khanna A, Morton H, Strauss K, Finegold D, Vockley J, et al. Domino liver transplantation (LT) in children and adults with maple syrup urine disease (MSUD). Am J Transplant 2008; 8: 539.
20. Mohan N, Karkra S, Kumaran V, Mohanka R, Mehta N, Rastogi A, et al. Twenty-two month liver recipient with maple syrup urine disease donates liver to another toddler: a report on the world's youngest domino pair. Liver Transpl 2010; 16 (suppl 1): S1-S284.
21. Gopasetty M, Soltys K, Bond J, Sindhi R, Nayyar N, Mazariegos G,. Domino liver transplantation from children and adults with maple syrup urine disease. Am J Transplant 2010; 10: 68-69.
22. Popescu I, Simionescu M, Tulbure D, Sima A, Catana C, Niculescu L, et al. Homozygous familial hypercholesterolemia: specific indication for domino liver transplantation. Transplantation 2003; 76: 1345-1350. (Pubitemid 37430722)
23. Popescu I, Habib N, Dima S, Hancu N, Gheorghe L, Iacob S, et al. Domino liver transplantation using a graft from a donor with familial hypercholesterolemia: seven-yr follow-up. Clin Transplant 2009; 23: 565-570.
24. Liu C, Niu DM, Loong CC, Hsia CY, Tsou MY, Tsai HL, Wei C,. Domino liver graft from a patient with homozygous familial hypercholesterolemia. Pediatr Transplant 2010; 14: E30-E33.
25. Danpure CJ,. Molecular and clinical heterogeneity in primary hyperoxaluria type 1. Am J Kidney Dis 1991; 17: 366-369.
26. Nolkemper D, Kemper MJ, Burdelski M, Vaismann I, Rogiers X, Broelsch CE, et al. Long-term results of pre-emptive liver transplantation in primary hyperoxaluria type 1. Pediatr Transplant 2000; 4: 177-181. (Pubitemid 30471305)
27. Watts RW, Danpure CJ, De Pauw L, Toussaint,. Combined liver-kidney and isolated liver transplantations for primary hyperoxaluria type 1: the European experience. The European Study Group on Transplantation in Hyperoxaluria Type 1. Nephrol Dial Transplant 1991; 6: 502-511.
28. Dunn SP, Tsai A, Griffin G, Toth S, Casas-Melley AT, Falkenstein KP, et al. Liver transplantation as definitive treatment for a factor V Leiden mutation. J Pediatr 2005; 146: 418-422. (Pubitemid 40341756)
29. Azoulay D, Samuel D, Castaing D, Adam R, Adams D, Said G, Bismuth H,. Domino liver transplants for metabolic disorders: experience with familial amyloidotic polyneuropathy. J Am Coll Surg 1999; 189: 584-593.
30. Pulvirenti A, Romito R, Sarli D, Montagnino G, Regalia E, Mazzarferro V,. Donor liver transplantation from a donor with primary hyperoxaluria type I. A case-report. In: Proceedings of the 6th European Workshop on Hyperoxaluria; April 2002; Hannover, Germany. Abstract 21.
31. Danpure C,. Primary hyperoxaluria. In:, Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B, eds. The Metabolic & Molecular Bases of Inherited Disease. 8th ed. New York, NY: McGraw-Hill; 2001: 3323-3367.
32. Korein J, Sansaricq C, Kalmijn M, Honig J, Lange B,. Maple syrup urine disease: clinical, EEG, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity. Int J Neurosci 1994; 79: 21-45.
33. Strauss KA, Mazariegos GV, Sindhi R, Squires R, Finegold DN, Vockley G, et al. Elective liver transplantation for the treatment of classical maple syrup urine disease. Am J Transplant 2006; 6: 557-564. (Pubitemid 43382143)
34. Netter JC, Cossarizza G, Narcy C, Hubert P, Ogier H, Revillon Y, et al. Mid-term outcome of 2 cases with maple syrup urine disease: role of liver transplantation in the treatment [in French]. Arch Pediatr 1994; 1: 730-734. (Pubitemid 24275505)
35. Kaplan P, Mazur A, Smith R, Olthoff K, Maller E, Palmieri M, et al. Liver transplantation for maple syrup urine disease (MSUD) and methylmalonic acidopathy (MMA). Am J Hum Genet 1997; 61: A254.
36. Schadewaldt P, Bodner-Leidecker A, Hammen HW, Wendel U,. Whole-body L-leucine oxidation in patients with variant form of maple syrup urine disease. Pediatr Res 2001; 49: 627-635. (Pubitemid 32390850)
37. Mazariegos GV, Morton DH, Sindhi R, Soltys K, Nayyar N, Bond G, et al. Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and comparative United Network for Organ Sharing experience. J Pediatr; doi:10.1016/j.jpeds.2011.06.033.
38. Barshop BA, Khanna A,. Domino hepatic transplantation in maple syrup urine disease. N Engl J Med 2005; 353: 2410-2411. (Pubitemid 41713759)
39. Bilheimer DW, Goldstein JL, Grundy SM, Starzl TE, Brown MS,. Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med 1984; 311: 1658-1664. (Pubitemid 15183996)
40. Goldstein JL, Hobbs HH, Brown MS,. Familial hypercholesterolemia. In:, Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B, eds. The Metabolic & Molecular Bases of Inherited Disease. 8th ed. New York, NY: McGraw-Hill; 2001: 2863-2913.
41. Naoumova RP, Thompson GR, Soutar AK,. Current management of severe homozygous hypercholesterolaemias. Curr Opin Lipidol 2004; 15: 413-422. (Pubitemid 39061621)
42. Bilheimer DW,. Portacaval shunt and liver transplantation in treatment of familial hypercholesterolemia. Arteriosclerosis 1989; 9 (suppl): I158-I163. (Pubitemid 19046979)
43. Castilla Cabezas JA, Lõpez-Cillero P, Jiménez J, Fraga E, Arizõn JM, Briceño J, et al. Role of orthotopic liver transplant in the treatment of homozygous familial hypercholesterolemia [in Spanish]. Rev Esp Enferm Dig 2000; 92: 601-608.
44. Lõpez-Santamaria M, Migliazza L, Gamez M, Murcia J, Diaz-Gonzalez M, Camarena C, et al. Liver transplantation in patients with homozygotic familial hypercholesterolemia previously treated by end-to-side portocaval shunt and ileal bypass. J Pediatr Surg 2000; 35: 630-633. (Pubitemid 30181048)
45. Shirahata Y, Ohkohchi N, Kawagishi N, Syouji M, Tsukamoto S, Sekiguchi S, et al. Living-donor liver transplantation for homozygous familial hypercholesterolemia from a donor with heterozygous hypercholesterolemia. Transpl Int 2003; 16: 276-279. (Pubitemid 36682186)
46. Starzl TE, Bilheimer DW, Bahnson HT, Shaw BW Jr, Hardesty RL, Griffith BP, et al. Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet 1984; 1: 1382-1383. (Pubitemid 14122021)
47. Maiorana A, Nobili V, Calandra S, Francalanci P, Bernabei S, El Hachem M, et al. Preemptive liver transplantation in a child with familial hypercholesterolemia. Pediatr Transplant 2011; 15: E25-E29.
48. Malatack JJ,. Liver transplantation as treatment for familial homozygous hypercholesterolemia: too early or too late. Pediatr Transplant 2011; 15: 123-125.
49. Moini M, Mistry P, Schilsky ML,. Liver transplantation for inherited metabolic disorders of the liver. Curr Opin Organ Transplant 2010; 15: 269-276.
50. Liu C, Loong CC, Hsia CY, Tsou MY, Tsai HL, Wei CF,. Venoplasty of hepatic venous outflow with a venous patch in domino liver transplantation. Liver Transpl 2008; 14: 1378-1379.